IL-12-engineered dendritic cells serve as effective tumor vaccine adjuvants in vivo

Laurence Zitvogel, Bettina Couderc, Jose I. Mayordomo, Paul D. Robbins, Michael T. Lotze, Walter J. Storkus

Research output: Contribution to journalArticlepeer-review

82 Scopus citations

Fingerprint

Dive into the research topics of 'IL-12-engineered dendritic cells serve as effective tumor vaccine adjuvants in vivo'. Together they form a unique fingerprint.

Medicine & Life Sciences

Arts & Humanities